First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2012-11-28 05:13:00Open Document File Size: 225,25 KBShare Result on FacebookCityNobler / Kaunas / New York / /CompanyMontgomery SA / IMS Health Inc. / Marley / Gilman AG / McGraw-Hill / /CountryFrance / United States / Italy / Canada / Australia / United Kingdom / Lithuania / Sweden / /CurrencyLTL / EUR / / /FacilityClinical Pharmacy / State Centre of Mental Health / Institute of Cardiology / Kaunas University of Medicine / Hall WD / /IndustryTermtreatment of depressive disorders / treatment of depression / depression treatment / health care systems / /MedicalConditiondepressive disorders / severe depression / melancholia / melancholic and severe depression / MS / depression / mental disorders / disorders / /OrganizationAudrius Sveikata Department of Theoretical and Clinical Pharmacology / World Health Organization / Institute of Cardiology / Department of Theoretical and Clinical Pharmacology / Kaunas University of Medicine / State Centre of Mental Health / WHO Collaborating Centre for Drug Statistics Methodology / Ministry of Health / State Medicines Control Agency / /PersonLoreta Mikučionytė / /PositionFarmer / general quality indicators / representative / /Productvenlafaxine / mirtazapine / Fluoxetine / escitalopram / Montanaro N. Prescriptions / Lithium carbonate / /ProvinceOrStateMississippi / /Technologypdf / /URLhttp /SocialTag |